Generic/Working Name | Apatinib |
Company Name | Hengrui Company |
Drug Type | Small molecule |
Drug Class | VEGFR |
Dose | 500 milligrams (mg) per flat dose |
Route | Oral (p.o.) |
Schedule of Administration | All patients received continuous apatinib 500 mg once daily until disease progression, death, intolerable toxicity, or patient request for withdrawal from the study occurred. Dose escalation was allowed. The dose decreased to 250 mg in patients who had grade 3 or higher adverse events. |